Publications by authors named "M Biasioli"
Purpose Of Review: To describe recent findings in endotyping occupational asthma by addressing the role of specific biomarkers.
Recent Findings: Studies on occupational asthma endotypes have focused on immune and inflammatory patterns associated with different occupational exposures to sensitizers or irritants.Sputum neutrophilia has been found in 58.
: In Italy, on December 2020, workers in the education sector were identified as a priority population to be vaccinated against COVID-19. The first authorised vaccines were the Pfizer-BioNTech mRNA (BNT162b2) and the Oxford-AstraZeneca adenovirus vectored (ChAdOx1 nCoV-19) vaccines. : To investigate the adverse effects of two SARS-CoV-2 vaccines in a real-life preventive setting at the University of Padova.
View Article and Find Full Text PDFObjectives: The aim of this study was to assess the predictors of a favourable prognosis of occupational asthma (OA) and the employment status of patients with OA at least 2 years after diagnosis.
Methods: We collected data from 204 patients who had a diagnosis of OA confirmed by a positive specific inhalation challenge. We defined OA remission as meeting the following three criteria: no asthma symptoms, no antiasthma therapy for the last year and having normal lung function at the end of follow-up.
Introduction: Since the 1990s there has been evidence of the significant role Flumazenil (FLU) has in benzodiazepines (BZD) detoxes. The Verona Detox approach has been developed for high dose BZD and Z-drug detoxification via continuous subcutaneous infusion of FLU, a selective BZD receptor antagonist acting on the BZD subunit of the GABA-A receptor. Flumazenil is licensed in the United Kingdom and other countries to treat only BZD overdose although numerous studies have demonstrated its effectiveness in rapidly resetting GABA-A receptors, quickly reducing tolerance and dependence from BZD, and providing a safe and rapid detox from benzodiazepines.
View Article and Find Full Text PDFArticle Synopsis
- The development of reduced-risk products aims to provide safer alternatives to traditional cigarettes for adult smokers, particularly by exploring the use of flavoring substances.
- While many flavoring agents are generally considered safe in food, their safety when inhaled remains uncertain and needs thorough evaluation.
- A comprehensive testing approach identified specific flavoring substances, such as citronellol and alpha-pinene, that impact the cytotoxicity of e-liquids, emphasizing the need for individual and mixture assessments for consumer safety.